Harmala Alkaloid MOIs

Our standard of care begins with the administration of harmala alkaloids, which inhibit the breakdown of monoamines, specifically seratonin, dopamine, and norepinephrine, and epinephrine. Harmalas bind with the monoamine oxidase enzymes in the gut, liver and brain, giving brain and body a boost in these neurochemicals that are often the underlying reason for many mood disorders. Research shows that monoamine oxidase enzymes are in oversupply in many individuals experiencing issues with their mood, caused by chronic stress.